Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Lower back and hips are connected by sacroiliac joints. Sacroiliitis inflames these joints. The rising prevalence of sacroiliitis changes the market. Lack of physical activity, an older population, and better information have increased detection rates, contributing to this rise.
New diagnostics have transformed the sacroiliitis market. Better imaging modalities like MRI, CT, and ultrasound have made sacroiliitis diagnosis simpler, growing the market. Treatment options affect sacroiliitis market development. NSAIDs, cortisone injections, physical therapy, and medications benefit sacroiliitis patients. New biologic medicines that target particular inflammatory pathways have increased medication availability and market share.
Biologic medications that target inflammatory pathways, such TNF, have altered sacroiliitis treatment. Sacroiliitis patients benefit from TNF inhibitors' reduced swelling and discomfort. Patients are handled differently and market share has increased.
Research and development impact the sacroiliitis market. Better and safer medicines are being developed by pharmaceutical corporations. New medicines and biologics in clinical trials expand therapeutic options and boost business.
Healthcare costs are going up, especially in developed countries, which affects the sacroiliitis market. Spending more on healthcare facilities, tests, and drugs is what makes the business grow. This is because these efforts make it easier to diagnose and treat sacroiliitis.
The market is affected by how much more patients and doctors know about the signs, diagnosis, and treatment of sacroiliitis. More efforts to educate and raise knowledge about patients lead to early identification and treatment, which increases market growth and changes the way patients are cared for.
The sacroiliitis market is affected by rules about drug development and market entry. Regulatory limits on drug study, approval, and marketing affect the difficulties of entering the pharmaceutical market. These restrictions hamper pharmaceutical companies' competitiveness.
The worldwide market for sacroiliitis is expanding as the ailment becomes more widespread and emerging nations improve their healthcare systems. These markets are rising due to global market trends including more healthcare spending, simpler service availability, and more knowledgeable customers.
 
Sacroiliitis Market Highlights:
Sacroiliitis Market Scenario
The Sacroiliitis Market is projected to reach USD 0.65 Billion by 2030 at 19.10% CAGR during the forecast period 2022-2030. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others. The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.
However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.
Segmentation
The sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis industry, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan. On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy. On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.
On the basis of region, the sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players in the sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.
Regional Market Summary
Sacroiliitis Market Share (%), by Region, 2017
Sources: Centers for Disease Control and Prevention
The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.
The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.
It is estimated that Europe stood second in the sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.
Asia-Pacific was projected to be the fastest growing region for the sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.
The Middle East and Africa holds the least share of the sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth.Â
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Market Segmentation and Key Market Players
Sacroiliitis Market, by Diagnosis,
- Imaging tests
- X-ray
- MRI
- CT scan
- Anesthetic injections
Sacroiliitis Market, by Treatment
- Medications
- Pain relievers
- Muscle relaxants
- TNF inhibitors
- Joint injections
- Radiofrequency denervation
- Electrical stimulation
- Joint fusion
- Facet block
- Chiropractic manipulation
- Physical therapy
Sacroiliitis Market, by End-User
- Hospitals & Clinics
- Pharmacies
- Diagnostic Centers
Sacroiliitis Market, by Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Sacroiliitis Market, by Key Players
- Medacta International
- SI-BONE
- Globus Medical
- Zyga Technology
- Nutech Medical
- CoorsTek Medical LLC
- Aspen Medical Products
- Medtronic
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
